Association Between Tumor Size and Prognosis in Patients With Small Bowel adenocarcinoma-a SEER-based Study
NCT ID: NCT06087887
Last Updated: 2023-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
8163 participants
OBSERVATIONAL
2023-01-01
2023-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Outcomes of Duodenal Adenocarcinoma From a Large Cohort
NCT06443086
Diagnosis, Treatment Status and Prognosis of Cholangiocarcinoma in China: a Multicenter, Two-way, Non-intervention Study
NCT04243057
Mechanism and Process Regulation for Colorectal Tumors
NCT04707482
The CSTME Associates With the Prognosis of Stage II and III Colorectal Cancer
NCT05420415
Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Reducing Recurrence of Colorectal Adenoma (CRA)
NCT06205862
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
tumor size 0-1cm
No intervention. Select small bowel adenocarcinoma patients with tumor size of 0-1 cm.
no interventions
no interventions
tumor size 1-2 cm
No intervention. Select small bowel adenocarcinoma patients with tumor size of 1-2 cm.
No interventions assigned to this group
tumor size 2-3 cm
No intervention. Select small bowel adenocarcinoma patients with tumor size of 2-3 cm.
No interventions assigned to this group
tumor size 3-4 cm
No intervention. Select small bowel adenocarcinoma patients with tumor size of 3-4 cm.
No interventions assigned to this group
tumor size 4-5 cm
No intervention. Select small bowel adenocarcinoma patients with tumor size of 4-5 cm.
No interventions assigned to this group
tumor size 5-6 cm
No intervention. Select small bowel adenocarcinoma patients with tumor size of 5-6 cm.
No interventions assigned to this group
tumor size 6-7 cm
No intervention. Select small bowel adenocarcinoma patients with tumor size of 6-7 cm.
No interventions assigned to this group
tumor size 7-8 cm
No intervention. Select small bowel adenocarcinoma patients with tumor size of 7-8 cm.
No interventions assigned to this group
tumor size 8-9 cm
No intervention. Select small bowel adenocarcinoma patients with tumor size of 8-9 cm.
No interventions assigned to this group
tumor size 9-10 cm
No intervention. Select small bowel adenocarcinoma patients with tumor size of 9-10 cm.
No interventions assigned to this group
tumor size >10 cm
No intervention. Select small bowel adenocarcinoma patients with tumor size of \>10 cm.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no interventions
no interventions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. received surgery and complete postoperative follow-up data;
3. histology type code 8140-8380.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhe Fan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhe Fan
docter
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dalian Third People's Hospital Affiliated to Dalian Medical University
Dalian, Liaoning, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ThirdPHDalian
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.